Former Advisor Now Whistleblower Exposes How FDA Approves Harmful Drugs

In a recent interview former Food and Drug Administration (FDA) advisor turned whistleblower exposed how the FDA approves harmful drugs.

Dr. Aaron S. Kesselheim, MPH, began advising the Food and Drug Administration (FDA) in 2015, and then joined one of its advisory panels as a permanent member in 2019.

At that time, he was ready to use the skills he’d acquired in a successful medical career to help guide the agency he much respected.

But then, the FDA approved a drug called ad...

Subscribe to view this content.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].